| | | Copy number loss | See cases | |
| | LOC123956257, LOC123956258 +2213 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | Multiple congenital anomalies/dysmorphic syndrome | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | CYP3A5, ZSCAN25 (T365M +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | CYP3A5, ZSCAN25 (P466H +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (M331T +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (R415C +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | | Single nucleotide variant (synonymous variant +2 more) | not provided | |
| | | Single nucleotide variant (synonymous variant +2 more) | CYP3A5-related disorder | |
| | CYP3A5, ZSCAN25 (S392P +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (P389S +2 more) | Single nucleotide variant (missense variant +2 more) | Essential hypertension | |
| | CYP3A5, ZSCAN25 (V371A +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (Y337C +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (T233fs +2 more) | Duplication (frameshift variant +2 more) | CYP3A5-related disorder | |
| | CYP3A5, ZSCAN25 (P231Q +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (D336Y +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (T196N +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (S299A +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | CYP3A5-related disorder | |
| | CYP3A5, ZSCAN25 (R260H +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (R142S +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (P118fs +2 more) | Deletion (frameshift variant +2 more) | CYP3A5-related disorder | |
| | | Single nucleotide variant (synonymous variant +2 more) | CYP3A5-related disorder | |
| | CYP3A5, ZSCAN25 (N192S +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (P159S +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (Y142H +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (L110S +2 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | appendicular lean mass relative to body height | |
| | CYP3A5, ZSCAN25 (S100Y +1 more) | Single nucleotide variant (missense variant +2 more) | CYP3A5-related disorder | |
| | CYP3A5, ZSCAN25 (V93L +1 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | CYP3A5-related disorder | |
| | | Single nucleotide variant (intron variant +1 more) | not provided | |
| | | Single nucleotide variant (intron variant +1 more) | Hypertension, salt-sensitive essential, susceptibility to +2 more | Gassociation; drug response; risk factor |
| | CYP3A5, ZSCAN25 (Y53H +1 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (L46F +1 more) | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, ZSCAN25 (L22fs +1 more) | Duplication (frameshift variant +2 more) | not provided | |
| | CYP3A5, ZSCAN25 (H20Y +1 more) | Single nucleotide variant (missense variant +2 more) | not provided | |
| | | Single nucleotide variant (5 prime UTR variant +3 more) | CYP3A5-related disorder | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | CYP3A5-related disorder | |
| | | Single nucleotide variant (missense variant +2 more) | not specified | |
| | CYP3A5, LOC110599592 +1 more | Single nucleotide variant (5 prime UTR variant +1 more) | CYP3A5-related disorder | |
| | CYP3A5, LOC110599592 +1 more | Single nucleotide variant (5 prime UTR variant +1 more) | CYP3A5-related disorder | |
| | | Deletion | not provided | |
| | | Copy number loss | not specified | |
| | | Copy number loss | not provided | |
| | | Copy number loss | not provided | |
| | | Duplication | not provided | |
| | | Copy number loss | See cases | |
| | CACNA2D1, CADPS2 +896 more | Complex | Ring chromosome 7 | |
| | | Deletion | not provided | |
| | | Copy number gain | not provided | |
| | ATP5MF-PTCD1, AZGP1 +127 more | Copy number gain | Isolated Pierre-Robin syndrome +1 more | |
| | | Copy number gain | not provided | |
| | | Copy number loss | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number loss | not provided | |
| | | Copy number loss | Split hand-foot malformation 1 | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Deletion | Pleomorphic xanthoastrocytoma | |
| | | Inversion | Childhood apraxia of speech | |